Trial Profile
A PHASE I TRIAL OF PF-03084014 IN PATIENTS WITH ADVANCED SOLID TUMOR MALIGNANCY AND T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Nirogacestat (Primary) ; Dexamethasone
- Indications Cancer; Fibroma; Precursor T-cell lymphoblastic leukaemia-lymphoma; Solid tumours
- Focus Adverse reactions
- Sponsors Pfizer
- 03 Apr 2017 Status changed from active, no longer recruiting to completed.
- 30 Nov 2016 Planned End Date changed from 1 Aug 2016 to 1 Nov 2016.
- 30 Nov 2016 Status changed from discontinued to active, no longer recruiting.